XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income [Member]
Total Dolby Laboratories,Inc.[Member]
Controlling Interest [Member]
Class A Common Stock [Member]
Common Stock [Member]
Class A Common Stock [Member]
Additional Paid-In Capital [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares, Outstanding   101              
Beginning balance at Sep. 29, 2017 $ 2,398,727   $ 61,331 $ 2,337,948 $ (7,753) $ 2,391,627 $ 7,100    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (53,158)     (53,302)   (53,302) 144    
Translation adjustments, net of tax of $829 and $(64), respectively 1,218       1,224 1,224 (6)    
Unrealized gains (losses) on available-for-sale securities, net of tax of $(327) and $(98), respectively (1,593)       (1,593) (1,593)      
Distributions to controlling interest (1,021)           (1,021)    
Stock-based compensation expense 18,684   18,684     18,684      
Shares repurchased (in shares)                
Repurchase of common stock (29,993)   (29,993)     (29,993)      
Cash dividends declared and paid on common stock (16,377)     (16,377)   (16,377)      
Common stock issued under employee stock plans 41,463   41,462     41,463   $ 1  
Tax withholdings on vesting of restricted stock (18,821)         (18,821)   $ (18,821)
Ending balance at Dec. 29, 2017 2,339,129   72,663 2,268,269 (8,122) 2,332,912 6,217    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares, Outstanding   102              
Shares, Outstanding   102              
Beginning balance at Sep. 28, 2018 2,370,503   66,127 2,313,539 (15,832) 2,363,936 6,567    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 98,358     98,219   98,219 139    
Translation adjustments, net of tax of $829 and $(64), respectively (3,728)       (3,577) (3,577) (151)    
Unrealized gains (losses) on available-for-sale securities, net of tax of $(327) and $(98), respectively 770       770 770      
Distributions to controlling interest (906)           (906)    
Stock-based compensation expense 21,482   21,482     21,482      
Shares repurchased (in shares)                
Repurchase of common stock (112,545)   (82,203) 30,342   (112,545)      
Cash dividends declared and paid on common stock (19,573)     (19,573)   (19,573)      
Tax benefit/(deficiency) from the stock incentive plans                
Common stock issued under employee stock plans 14,272   14,272     14,272    
Tax withholdings on vesting of restricted stock (19,679)         (19,679)   $ (1) $ (19,678)
Ending balance at Dec. 28, 2018 $ 2,348,954   $ 0 $ 2,361,843 $ (18,639) $ 2,343,305 $ 5,649    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares, Outstanding   101